Immunohistochemical evaluation of cyclooxygenase expression in corneal squamous cell carcinoma in horses.
Abstract: To evaluate expression of cyclooxygenase (COX)-1 and COX-2 in the cornea, eyelid, and third eyelid of healthy horses and those affected with squamous cell carcinoma (SCC) by use of immunohistochemical techniques. Methods: 15 horses with SCC involving ocular tissues and 5 unaffected control horses. Methods: SCC-affected tissues were obtained from the cornea (n = 5 horses), eyelid (5), and third eyelid (5). Site-matched control tissues were obtained from 5 horses unaffected with SCC. Tissue sections of affected and control cornea, eyelid, and third eyelid were stained immunohistochemically for COX-1 and COX-2 via standard techniques. Stain uptake was quantified by use of computer-assisted image analysis of digital photomicrographs. Results: Immunoreactivity for both COX-1 and COX-2 was significantly greater in equine corneas with SCC than in control corneas. No significant differences in COX-1 or COX-2 immunoreactivity were detected in eyelid and third-eyelid SCC, compared with site-matched control tissues. Conclusions: Immunoreactivity for COX-1 and COX-2 is high in equine corneal SCC, possibly indicating that COX plays a role in oncogenesis or progression of this tumor type at this site. Pharmacologic inhibition of COX may represent a useful adjunctive treatment for corneal SCC in horses.
Publication Date: 2007-02-03 PubMed ID: 17269882DOI: 10.2460/ajvr.68.2.165Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research studied the expression of cyclooxygenase (COX) enzymes in the eye tissues of healthy horses and those with squamous cell carcinoma (SCC), a type of skin cancer. The results showed higher COX levels in cancer-affected equine corneas than in healthy ones, indicating COX could be involved in the development or progression of corneal SCC, and the use of COX-inhibitors might be a helpful complementary treatment.
Research Methodology
- The study involved 15 horses with SCC involving ocular tissues i.e. the cornea, eyelid, and third eyelid; and 5 healthy horses were used as controls.
- From the SCC-affected horses, the researchers obtained tissues from the cornea (5 horses), eyelid (5 horses), and third eyelid (5 horses).
- To compare, tissues from the same sites were collected from the 5 healthy horses.
- Both the affected and control tissues were then stained using immunohistochemical techniques to detect COX-1 and COX-2.
- A standard technique to evaluate the uptake of the stain was used, and computer-assisted image analysis of digital pictures was carried out to quantify this.
Research Findings
- The key finding was that both COX-1 and COX-2 immunoreactivity was significantly greater in the corneas of horses with SCC than in the control group.
- Notably, there were no significant differences observed in COX-1 or COX-2 immunoreactivity in SCC of the eyelid and the third eyelid, when compared to healthy tissues from the same sites. This indicates that the correlation between increased COX expression and SCC may be specific to the cornea.
Conclusions
- The results suggest that COX-1 and COX-2 could play a role in the development or progression of SCC in the corneas of horses.
- Based on this, the use of drugs that inhibit COX may be beneficial as an additional treatment strategy for corneal SCC in horses. This could potentially help to reduce the impact or spread of the cancer, though further research would be needed to confirm the effectiveness and safety of such an approach.
Cite This Article
APA
McInnis CL, Giuliano EA, Johnson PJ, Turk JR.
(2007).
Immunohistochemical evaluation of cyclooxygenase expression in corneal squamous cell carcinoma in horses.
Am J Vet Res, 68(2), 165-170.
https://doi.org/10.2460/ajvr.68.2.165 Publication
Researcher Affiliations
- Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri-Columbia, Columbia, MO 65211, USA.
MeSH Terms
- Animals
- Carcinoma, Squamous Cell / metabolism
- Carcinoma, Squamous Cell / veterinary
- Cornea / enzymology
- Cornea / pathology
- Cyclooxygenase 1 / metabolism
- Cyclooxygenase 2 / metabolism
- Eye Neoplasms / metabolism
- Eye Neoplasms / veterinary
- Female
- Gene Expression Regulation, Enzymologic
- Horse Diseases / metabolism
- Horses
- Immunohistochemistry / veterinary
- Liver / enzymology
- Liver / pathology
- Male
Citations
This article has been cited 1 times.- Wotman KL, Chow L, Martabano B, Pezzanite LM, Dow S. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia.. Cancer Immunol Immunother 2023 May;72(5):1185-1198.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists